Table 2. Clinical characteristics of admitted young adults COVID-19 –vital signs and laboratory measures (median, IQR).
| Vital Signs [Median (IQR)] | Alive | Deceased | All Patients |
|---|---|---|---|
| Temperature (°C) | 100.2 (2.925) | 100.1 (2.675) | 100.2 (2.90) |
| Heart rate (beats per min) | 111 (22) | 117 (23.75) | 111 (22) |
| Oxygen saturation (%) | 94 (5) | 94.5 (12.75) | 94 (6) |
| Labs* [Median (IQR)] | Alive | Deceased | All Patients |
| White blood cell count (×103 cells per μL), n = 387 | 7.59 (4.5) | 8.03 (6.49) | 7.67 (4.63) |
| Neutrophil (%), n = 385 | 77.6 (13.28) | 79 (13.1) | 77.95 (13.15) |
| Lymphocyte (%), n = 385 | 14.75 (11.2) | 13.1 (10.7) | 14.6 (11.2) |
| Creatinine (mg/dL), n = 385 | 0.84 (0.35) | 0.97 (0.85) | 0.86 (0.40) |
| Glucose (mg/dL), n = 386 | 111 (40) | 139.5 (176) | 113 (49) |
| Aspartate aminotransferase (U/L), n = 374 | 44 (42) | 87 (139) | 46 (50.5) |
| Alanine aminotransferase (U/L), n = 374 | 44 (46) | 54 (79) | 46 (52.75) |
| Lactate Dehydrogenase (x/x), n = 291 | 395 (209) | 491 (389) | 406 (226) |
| C-reactive protein (mg/L), n = 269 | 64.74 (128.6) | 73 (155) | 66.1 (135.39) |
| Ferritin (ng/mL), n = 261 | 748 (972) | 776.3 (1093) | 751 (976.1) |
| Procalcitonin (ng/mL) n = 326 | 0.19 (0.28) | 0.42 (1.2) | 0.21 (0.38) |
| D-dimer (μg/mL), n = 245 | 333.5 (337) | 453 (1502) | 354 (355) |
| Hgb a1C, n = 85 | 6.55 (5.4) | 10.5 (8.8) | 6.6 (6) |
| High-sensitivity cardiac troponin T (ng/L), n = 53 | 0.01 (0.03) | 0.035 (0.15) | 0.02 (0.06) |
#Temperature, heart rate, SPO2 at hospital presentation
*median values, IQR, n = number of patients with laboratory